Serum metabolomic signatures of patients with rare neurogenetic diseases: an insight into potential biomarkers and treatment targets

IntroductionTo further advance our understanding of Muscular Dystrophies (MDs) and Spinocerebellar Ataxias (SCAs), it is necessary to identify the biological patterns associated with disease pathology. Although progress has been made in the fields of genetics and transcriptomics, there is a need for...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Nalaka Wijekoon, Lakmal Gonawala, Pyara Ratnayake, Darshana Sirisena, Harsha Gunasekara, Athula Dissanayake, Dhammika Amaratunga, Harry W. M. Steinbusch, Yetrib Hathout, Eric P. Hoffman, Ashwin Dalal, Chandra Mohan, K. Ranil D. de Silva
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-01-01
Serija:	Frontiers in Molecular Neuroscience
Teme:	muscular dystrophy ataxia biomarker DMD LGMD SCA
Online dostop:	https://www.frontiersin.org/articles/10.3389/fnmol.2024.1482999/full
Oznake:	Označite Brez oznak, prvi označite!